Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Non-Current Assets: 2012-2024

Historic Non-Current Assets for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $4.3 million.

  • CorMedix's Non-Current Assets rose 10986.07% to $491.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $491.3 million, marking a year-over-year increase of 10986.07%. This contributed to the annual value of $4.3 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Non-Current Assets stood at $4.3 million for FY2024, which was up 71.70% from $2.5 million recorded in FY2022.
  • In the past 5 years, CorMedix's Non-Current Assets ranged from a high of $4.3 million in FY2024 and a low of $1.1 million during FY2020.
  • In the last 2 years, CorMedix's Non-Current Assets had a median value of $3.4 million in 2022 and averaged $3.4 million.
  • Data for CorMedix's Non-Current Assets shows a peak YoY spiked of 787.98% (in 2020) over the last 5 years.
  • Yearly analysis of 4 years shows CorMedix's Non-Current Assets stood at $1.1 million in 2020, then spiked by 119.93% to $2.5 million in 2021, then grew by 0.42% to $2.5 million in 2022, then reached $4.3 million in 2024.